BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11094033)

  • 1. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.
    Vehkavaara S; Hakala-Ala-Pietilä T; Virkamäki A; Bergholm R; Ehnholm C; Hovatta O; Taskinen MR; Yki-Järvinen H
    Circulation; 2000 Nov; 102(22):2687-93. PubMed ID: 11094033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state.
    Kawano H; Yasue H; Hirai N; Yoshida T; Fukushima H; Miyamoto S; Kojima S; Hokamaki J; Nakamura H; Yodoi J; Ogawa H
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):346-53. PubMed ID: 12940591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women.
    Vihma V; Vehkavaara S; Yki-Järvinen H; Hohtari H; Tikkanen MJ
    J Clin Endocrinol Metab; 2003 Feb; 88(2):588-93. PubMed ID: 12574185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
    Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
    Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
    J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
    Sanada M; Tsuda M; Kodama I; Sakashita T; Nakagawa H; Ohama K
    Menopause; 2004; 11(3):331-6. PubMed ID: 15167313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low testosterone levels are associated with endothelial dysfunction in oophorectomized early postmenopausal women.
    Rech CM; Clapauch R; de Souza Md; Bouskela E
    Eur J Endocrinol; 2016 Mar; 174(3):297-306. PubMed ID: 26773076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women.
    Vehkavaara S; Westerbacka J; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Yki-Järvinen H
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4663-70. PubMed ID: 11134125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Am J Cardiol; 1995 Feb; 75(4):264-8. PubMed ID: 7832136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.